The Tsinghua University epidemic feels real. Tsinghua Peking University's anti-epidemic incident is true, and Tsinghua released the latest research and development results of COVID-19's "specific drugs". The first specific drug of ambroxol combined with lomax monoclonal antibody developed by Professor Zhang of the School of Medicine of our school has been approved for marketing, which also marks the official appearance of the first self-developed and proven effective anti-specific drug in China. Tsinghua University (hereinafter referred to as "Tsinghua"), located in Haidian District, is a national key university directly under the Ministry of Education of People's Republic of China (PRC). It ranks among the national "Double First Class", "985 Project" and "21project" and is selected as "20 165438+".